The Food and Drug Administration has approved a treatment for managing a type of bacterial infection in patients with cystic fibrosis.
A panel of Food and Drug Administration experts is recommending that the agency approve an experimental drug for cystic fibrosis made by Novartis, the Swiss drug maker said.
Fera Pharmaceuticals has launched a preservative-free ointment for treating bacterial infections of the eye, the...